Here are five key trends:
1. Some major factors supporting the spinal fusion market growth in China are the increasing rate of aging population with spine-related diseases and injuries as well as Chinese residents’ rising incomes.
2. The emergence of advanced technologies, such as minimal invasive surgery and enhanced implant materials, are allowing people of all age groups to receive fusion procedures, leading to further market growth.
3. Additionally, the price sensitive Chinese population is responsive to the treatment price that is anticipated to drop considerably due to the increasing market competition.
4. Factors restraining the China spinal fusion market include reimbursement cuts, heavy government regulations and surgical risk factors.
5. Some key players in the China spinal fusion market are Depuy Synthes, Zimmer Biomet, Medtronic, NuVasive, Stryker, Orthofix, B. Braun Aesculap, Trauson and Weigao Orthopaedic Device Company, which signed an exclusive distribution agreement with Amedica in April.
More articles on spine:
5-year cervical disc replacement results vs. spinal fusion: 5 key notes
UCLA pays $8.5M to settle 2 lawsuits after undisclosed spine surgeon relationship with Medtronic: 5 key notes
Are 3-month ODI scores sufficient in determining long-term outcomes after lumbar spine surgery? 6 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
